openPR Logo
Press release

Customized Therapy for Breast Cancer Patients

08-26-2013 05:23 PM CET | Health & Medicine

Press release from: Fraunhofer MEVIS

Researchers in the VPH-PRISM project develop new procedures to improve treatment of breast cancer using multidisciplinary image data.

Every tenth woman is afflicted with breast cancer during her lifetime.The diagnosis and treatment of a patient involves the collaboration of a wide range of specialists. The broad range of software platforms for storage and visualization of medical imaging data used by radiologists, pathologists, oncologists, radiotherapists and surgeons, brings challenges for communication and data transfer between the platforms. Improved extraction and transfer of information between the platforms may support breast cancer diagnosis and therapy planning.

This is where the VPH-PRISM project comes into play. Eight research partners and one coordinating partner are developing novel software systems that intelligently connect medical data sets to allow innovative assistive functions. The researchers plan to combine image data generated by various diagnostic procedures (X-ray, MRI, tissue histology) for display in a single software application. Their vision consists of systematically gathering and quantitatively combining the image information currently available from various disciplines. For the first time, this would permit a large number of microscopic and macroscopic tissue parameters to be correlated efficiently and precisely. This could provide important indicators, enabling clinicians to customize therapy planning for individual patients.

To realize this, researchers in the project intend to create an interactive database to connect images with other relevant information, such as a patient’s risk of hereditary disease and environmental factors. This database would allow development of more focused therapy for breast cancer patients in the future. The Fraunhofer Institute for Medical Image Computing MEVIS in Bremen has taken charge of the scientific coordination of the project and is responsible for developing significant sections of the required image analysis procedures.

Early detection and therapy for breast cancer typically involves multiple disciplines. Radiologists interpret X-ray and MRI scans of the patient breast, whereas pathologists use 40x magnification and higher to examine the spatial arrangement of single cells from breast tissue samples. Surgeons attempt to remove malignant tumors effectively while conserving as much healthy tissue as possible. Radiotherapists treat breast cancer with radiation, and oncologists decide which type of chemotherapy is expected to be most beneficial.

An important challenge is to increase the interconnectivity of the information technology systems of these different disciplines. Radiologists and pathologists often work in the same hospital with different IT systems, each partly optimized to display and manipulate only the specialists’ own image data. When experts from different fields discuss suitable therapies, different image storage systems may result in abbreviated data transfer possibilities. Interdisciplinary tumor board meetings, during which specialists discuss individual breast cancer cases, may benefit from increased interconnectivity of the different systems.

To improve this situation, VPH-PRISM partners are developing software for X-ray, MRI images, ultrasound, and histology from biopsies, to provide a unified display to spatially superimpose, measure, and manipulate these images. Especially helpful would be the ability to characterize the area surrounding a tumor more accurately. The project will aim to answer the questions: has this tissue changed to such a degree that it must be removed with the tumor during the operation, or can a more local excision, exposing the patient to a less invasive operation, be performed without the risk of recurrence?

To accomplish this, tissue sample pathology slides must be digitized. However, digitization generates large amounts of data, which pathologists can only partially inspect. To solve this, VPH-PRISM experts are also developing software that automatically preselects and preprocesses the data, thereby facilitating the work of the pathologist. If the venture is successful, experts estimate that digital pathology will promote a breakthrough in breast cancer care similar to the effect that the widespread introduction of mammography had on early detection that has occurred over the last 15 years.

The project will explore how a deep understanding of tissue microstructure, gleaned from histology, can aid interpretation of X-ray, MRI, and ultrasound images. Additionally challenging is the presentation of tissue sample images alongside MRI and X-ray images. Experts using computationally intensive algorithms must guarantee that multiple data sets fit perfectly together. Only in this manner can tissue parameters gathered using different scalings be spatially correlated and hence superimposed.

The goal is a software tool that supports clinicians when choosing therapy. Patient data should be grouped automatically according to shared criteria. This allows the software to provide clues for optimal chemotherapy, for instance, if a patient with particular tissue characteristics has been assigned to a particular group. This could prove useful for monitoring the progress of therapy more accurately: Is the tumor degenerating as quickly as expected when a patient undergoes a certain type of chemotherapy? If not, then the doctor could cease ineffective therapy in a timely fashion and provide the patient with alternative drugs.

About VPH-PRISM

VPH-PRISM stands for “Virtual Physiological Human: Personalized Predictive Breast Cancer Therapy Through Integrated Tissue Micro-Structure Modeling.” The project is financed by the EU with a sum of 3.7 million euro, beginning in March 2013 and ending in February 2016. The consortium is composed of nine partners from five countries, including research institutes, clinical breast centers, and Philips Research.
• EIBIR, European Institute for Biomedical Imaging Research, Vienna, Austria (project coordinator)
• Fraunhofer Institute for Medical Image Computing MEVIS, Bremen, Germany (scientific coordinator)
• Radboud University Nijmegen Medical Center, The Netherlands
• University College London, UK
• University of Dundee, UK
• University of Chicago, USA
• Medical University of Vienna, Austria
• Boca Raton Regional Hospital, USA
• Philips Research, Hamburg, Germany

Website:

http://www.vphprism.eu

Fraunhofer MEVIS develops interactive assistance systems for clinical routines. This development focuses on medical image data used in early detection, diagnosis, therapy planning, therapy support, or follow-up.

Bianka Hofmann
Fraunhofer MEVIS
Institute for Medical Image Computing
Universitätsallee 29
28359 Bremen

Tel.:+49 421 218 59231
Fax: +49 421 218 98 59231
bianka.hofmann@mevis.fraunhofer.de
www.mevis.fraunhofer.de

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Customized Therapy for Breast Cancer Patients here

News-ID: 262704 • Views:

More Releases from Fraunhofer MEVIS

Intelligent Software for Patient-Friendly Radiation Therapy - The SPARTA Researc …
X-rays can provide much more than radiography for diagnosing bone fractures or internal disease. In the form of high-energy photon beams, cancer can be treated by exposing tumors to a strong dose of targeted radiation. This type of radiation therapy is currently one of the most important treatment methods for cancer; about half of all tumor patients are now treated with photon or particle beams. The novel, interdisciplinary SPARTA project

More Releases for MRI

MRI-guided Neurosurgical Ablation Market Opportunity by 2028 | Insightec Lmt, An …
According to the latest market report published by Future Market Insights titled ‘MRI-Guided Neurosurgical Ablation Market: Global Industry Analysis 2013–2017 and Opportunity Assessment 2018–2028’, the global MRI-guided neurosurgical ablation market is projected to expand at a CAGR of 4.9% during the forecast period 2018–2028 and reach US$ 216.3 Mn by the end of 2028. Global MRI-guided Neurosurgical Ablation Market: Dynamics The per capita healthcare expenditure is currently following an uptrend across both
MAGNETIC RESONANCE IMAGING (MRI) SYSTEM MARKET 2025: BY FIELD STRENGTH (HIGH FIE …
Global Magnetic Resonance Imaging (MRI) System Market Expected to Reach XX Million by 2025  According to a new report published by Reports Monitortitled, “Magnetic Resonance Imaging (MRI) System Market By Architecture & Field Strength: Global Opportunity Analysis and Industry Forecast, 2017–2025,” the Magnetic Resonance Imaging (MRI) system market was valued at XX million in 2016, and is projected to reach at XX million by 2025, growing at a CAGR of XX% from
Magnetic Resonance Imaging (MRI) Systems Market by Field Strength (High-Field MR …
Global Magnetic Resonance Imaging (MRI) Systems Market was valued at USD 5.63 Billion in the year 2017. Global Magnetic Resonance Imaging (MRI) Systems Market is further estimated to grow at a CAGR of 4.02% from 2018 to reach USD 7.13 Billion by the year 2023. The North America region holds the highest market share in 2018 and the Asia Pacific is considered as the fastest growing market in the forecasted
Magnetic Resonance Imaging (MRI) Market Global Growth +5.5% CAGR, Architecture ( …
Magnetic Resonance Imaging Devices Market accounted to USD 6.1 billion in 2016 growing at a CAGR of 5.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Global Magnetic Resonance Imaging (MRI) Market – By Architecture (Closed MRI System, Open MRI System), By Field Strength (Low Field
Magnetic Resonance Imaging (MRI) Market Growth +5.5% CAGR, Architecture (Closed …
Magnetic Resonance Imaging Devices Market accounted to USD 6.1 billion in 2016 growing at a CAGR of 5.5% during the forecast period of 2017 to 2024. The upcoming market report contains data for historic years 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024. Free Sample Report of Global Magnetic Resonance Imaging (MRI) Market @ http://databridgemarketresearch.com/request-a-sample/?dbmr=global-magnetic-resonance-imaging-mri-market Global Magnetic Resonance Imaging (MRI) Market – By Architecture
Market Application Of Global MRI Guided Neurosurgical Ablations, Growth Elements …
Qyresearchreports include new market research report "Global MRI Guided Neurosurgical Ablations Market Size, Status and Forecast 2022" to its huge collection of research reports. Every key element that has happened so far in the MRI Guided Neurosurgical Ablations has been represented in this widely inclusive report. A key portion of these market elements incorporate the key player profiles and the market's general competitive scene, as players are known to have what's